Davide Gibellini
Davide Gibellini is an expert in Infectiology at Azienda Ospedaliera Universitaria Integrata Verona (Italy). Davide Gibellini has authored 252 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 667 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Genetics - Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1991 - 2026
Number : 252
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a Gba1-Deficient Synucleinopathy Model. PMID 42651749 — hiv-1, stress, physiological, brain, synucleinopathies, hiv, genes, tat, tissues, environment, synucleins | Curr Issues Mol Biol | 2026 | 0 |
| HIV-1 Tat and gp120 as key drivers of neurodegeneration in the central nervous system. PMID 42656799 — hiv-1, aging, brain, central nervous system, hiv, genes, tat, therapeutics, viral proteins, nervous system | Front Microbiol | 2026 | 0 |
| c-FLIP as a master regulator of immune homeostasis and disease mechanisms. PMID 42020362 — cells, homeostasis, immunity, receptors, death domain, therapeutics, apoptosis, cell death | Cell Death Dis | 2026 | 0 |
| Host transcriptomic analysis reveals a defective intracellular environment that limits SARS-CoV-2 replication in CFTR-deficient airway epithelium. PMID 41959565 — cells, genes, sars-cov-2, transcriptome, cystic fibrosis, cell biology, covid-19, severe acute respiratory syndrome-related coronavirus, environment, epithelium, infections | Front Cell Infect Microbiol | 2026 | 0 |
| When viruses meet cystic fibrosis: Insights into host-pathogen dynamics. PMID 41930828 — genes, respiratory syncytial viruses, lung, incidence, environmental microbiology, fibrosis, microbiology, biotechnology, herpesvirus 4, human, cystic fibrosis, influenza, human, viruses, orthomyxoviridae, infections, virus diseases | Microbiol Res | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map